The 2023 Technology and Life Sciences PIPE and RDO Report presents analysis related to 177 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and December 31, 2023.

Please see full publication below for more information.

ncG1vNJzZmivp6x7q7DSrqermV6YvK57y56emqSemsS0e5FpaWxlpJqwqbrOpaagsV2Wu6V5y6KdnmWjmLamusKeqmaomaWybn6Xb2duaGFk